Skip to content

Retrospective Review of Gastrointestinal System Endoscopy Procedures

Retrospective Review of Gastrointestinal System Endoscopy Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05012527
Acronym
RRGIE
Enrollment
15448
Registered
2021-08-19
Start date
2021-06-11
Completion date
2021-10-01
Last updated
2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biopsy, Colonic Polyps, Colonoscopy, Endoscopy, Endoscopy, Digestive System, Gastrointestinal Neoplasms, Gastroscopy

Brief summary

The aim of the study is retrospectively evaluating all features of endoscopic and pathological diagnoses of cases who underwent upper and lower gastrointestinal endoscopy.

Detailed description

Gastrointestinal system endoscopy has an important place in the diagnosis and treatment of many diseases related to this system and provides an alternative to current surgical methods with its ever-expanding field of application. Upper and lower gastrointestinal endoscopy procedures are performed with many indications, such as new complaints in the gastrointestinal tract at the age of 50 and over, family history of gastrointestinal malignancy. In addition, the importance of endoscopy is gradually increasing as tissue and cell samples can be taken for histopathological studies and endoscopic treatment of some diseases. The aim of the study is to review patients' indications, distribution by age and gender, frequency of lesions diagnosed on endoscopy, prevalence, size, histology and location of polyps detected and excised, results of endoscopic and pathological diagnoses. The study population consists of the patients who were examined at the Istanbul Sultanbeyli State Hospital Endoscopy Unit between 01.01.2016 and 01.01.2021. The patients' data will be scanned retrospectively by accessing their files from the computer database.

Interventions

None listed

Sponsors

Istanbul Sultanbeyli State Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients (over 18 years old) * Patients who have undergone the procedure in our endoscopy unit

Exclusion criteria

* Under 18 years old * Patients whose information cannot be accessed in the system records.

Design outcomes

Primary

MeasureTime frameDescription
Non-neoplastic biopsy resultsDuring 3 months (retrospective endoscopy data review)The patients with non-neoplastic biopsy results / the total patients
Prevalence of gastric/bowel diseases in histopathologyDuring 3 months (retrospective endoscopy data review)The patients with gastric disease / the total patients The patients with bowel disease / the total patients
Prevalence of advanced neoplasiaDuring 3 months (retrospective endoscopy data review)The patients with advanced neoplasia / the total patients
Prevalence of gastric/colorectal cancerDuring 3 months (retrospective endoscopy data review)The patients with gastric cancer / the total patients The patients with colorectal cancer / the total patients
AgeDuring 3 months (retrospective endoscopy data review)Age distribution of patients in endoscopic procedures and histopathological examinations
GenderDuring 3 months (retrospective endoscopy data review)Sex distribution of patients in endoscopic procedures and histopathological examinations
Type of endoscopyDuring 3 months (retrospective endoscopy data review)Number of each endoscopy, Type (esophagogastroduodenoscopy, colonoscopy, rectosigmoidoscopy)
IndicationsDuring 3 months (retrospective endoscopy data review)Number of endoscopic indications, Type (Abnormal imaging, GI bleeding, Anemia, Screening and surveillance, Diarrhea, Constipation, Abdominal pain, Weight loss, Dyspepsia, Heartburn, Dysphagia, Odynophagia, Upper belly pain or chest pain that is not heart-related, Intractable vomiting, Bleeding in the upper, Persistent gastroesophageal reflux symptoms, Occult gastrointestinal bleeding, Other)
Procedure-related complications ratesDuring 3 months (retrospective endoscopy data review)The patients with complications / the total patients Number of adverse events; early or late (within 1 month), related to the endoscopic procedure, Type (cardiopulmonary complication, gastrointestinal bleeding, perforation, mortality)
Prevalence of benign/malign gastrointestinal disease in the endoscopyDuring 3 months (retrospective endoscopy data review)The patients with benign gastrointestinal disease / the total patients The patients with malign gastrointestinal disease / the total patients
Polyp/tumor detection rate of screening endoscopyDuring 3 months (retrospective endoscopy data review)The patients with polyp / the total number of screening endoscopy patients The patients with tumor / the total number of screening endoscopy patients
Polyp/tumor detection rate of symptomatic patients' endoscopyDuring 3 months (retrospective endoscopy data review)The patients with polyp / the total number of symptomatic patients endoscopy The patients with tumor / the total number of symptomatic patients endoscopy
Polyps localization and frequencyDuring 3 months (retrospective endoscopy data review)The patients with polyp / the total patients Number of polyp localizations, Type (Rectum, Sigmoid colon, Descending colon, Splenic flexure, Transverse colon, Hepatic flexure, Ascending colon, Caecum, Multiple localization)
Completeness rate of the proceduresDuring 3 months (retrospective endoscopy data review)The number of completed procedures / total number of procedures

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026